Watching the pps after we see sentiment and volume move the pps up to .92 just to fall back to .63 today! Incredible! All manipulated fluff. Now that FDA has made and offer to review July 6? What? There should be solid sentiment for buyers and the pps will rise after it bottoms soon? Can't believe the clinical study and other requests for more information YET still needs to meet? Is this big pharm or the FDA subtly acknowledging the market effect of a hemostasis product like no other! IMO you have to see the approval in a more broader review are positioning themselves for review and approval of other similar apps and approvals as well as the gel and foam hemostyp products!
$5-$10+